These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 11335878)

  • 1. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
    Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F
    Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virus-related infection.
    Peoc'h K; Dubel L; Chazouillères O; Ocwieja T; Duron F; Poupon R; Johanet C
    Am J Gastroenterol; 2001 Oct; 96(10):2978-83. PubMed ID: 11693336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha.
    Kansu A; Kuloğlu Z; Demirçeken F; Girgin N
    Turk J Gastroenterol; 2004 Dec; 15(4):213-8. PubMed ID: 16249973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of HCV antibodies in autoimmune thyroid disease.
    Testa A; Castaldi P; Fant V; Fiore GF; Grieco V; De Rosa A; Pazardjiklian MG; De Rosa G
    Eur Rev Med Pharmacol Sci; 2006; 10(4):183-6. PubMed ID: 16910348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between human leukocyte antigen (HLA) and interferon- induced thyroid diseases in four patients with HCV-related chronic hepatitis.
    Labbadia G; Martocchia A; Mammarella A; Paoletti V; Rocco A; Benvenuto R; Antonella P; Rosaria D; Trabace S; Musca A; Falaschi P
    Neuro Endocrinol Lett; 2005 Apr; 26(2):109-12. PubMed ID: 15855880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.
    Martocchia A; Labbadia G; Paoletti V; Gargano S; Grossi A; Trabace S; Musca A; Falaschi P
    Neuro Endocrinol Lett; 2001; 22(1):49-52. PubMed ID: 11335880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study.
    Ganne-Carrie N; Medini A; Coderc E; Seror O; Christidis C; Grimbert S; Trinchet JC; Beaugrand M
    J Autoimmun; 2000 Mar; 14(2):189-93. PubMed ID: 10677250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection.
    Indolfi G; Stagi S; Bartolini E; Salti R; de Martino M; Azzari C; Resti M
    Clin Endocrinol (Oxf); 2008 Jan; 68(1):117-21. PubMed ID: 17692107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy.
    Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Suzuki F; Akuta N; Someya T; Hosaka T; Kobayashi M; Kumada H
    J Gastroenterol; 2004; 39(5):455-60. PubMed ID: 15175944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
    Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
    Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy.
    Deutsch M; Dourakis S; Manesis EK; Gioustozi A; Hess G; Horsch A; Hadziyannis S
    Hepatology; 1997 Jul; 26(1):206-10. PubMed ID: 9214471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoimmune hepatitis and/or hepatitis C].
    Simonović J; Dokić Lj; Svirtlih N; Djordjević M; Bozić N; Poluga J
    Srp Arh Celok Lek; 1999; 127(3-4):109-13. PubMed ID: 10500434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid disease in HCV carriers undergoing antiviral therapy with interferon plus ribavirin.
    Paraná R; Cruz M; Santos-Jesus R; Ferreira K; Codes L; Cruz T
    Braz J Infect Dis; 2000 Dec; 4(6):284-90. PubMed ID: 11136525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
    Huang JF; Chuang WL; Dai CY; Chen SC; Lin ZY; Lee LP; Lee PL; Wang LY; Hsieh MY; Chang WY; Yu ML
    J Viral Hepat; 2006 Jun; 13(6):396-401. PubMed ID: 16842442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid dysfunction in antiviral therapy of chronic hepatitis C.
    Dabrowska MM; Panasiuk A; Flisiak R
    Hepatogastroenterology; 2010; 57(101):826-31. PubMed ID: 21033237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial.
    Villa E; Grottola A; Buttafoco P; Colantoni A; Bagni A; Ferretti I; Cremonini C; Bertani H; Manenti F
    Am J Gastroenterol; 2001 Oct; 96(10):2973-7. PubMed ID: 11693335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha.
    Matsuda J; Saitoh N; Gotoh M; Gohchi K; Tsukamoto M; Syoji S; Miyake K; Yamanaka M
    Am J Gastroenterol; 1995 Jul; 90(7):1138-41. PubMed ID: 7611213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.
    Pellicano R; Smedile A; Peyre S; Astegiano M; Saracco G; Bonardi R; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):55-61. PubMed ID: 15756146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytokine therapy and the endocrine system: is it necessary to monitor more than the thyroid gland?].
    Schuppert F; Müller-Kunert E; Stöcker W; Bokemeyer C; Schmoll HJ; von zur Mühlen A; Rambusch EG
    Med Klin (Munich); 1996 Feb; 91(2):59-65. PubMed ID: 8850099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.